Rhaeos
Evanston
About Rhaeos
Rhaeos, the world's first wearable shunt monitor, aims to improve the quality of care for patients with hydrocephalus through a novel, thermal biosensor. Developed within Northwestern University with collaboration between Dr. John Rogers, McCormick School of Engineering, Feinberg School of Medicine, and Kellogg School of Management, Rhaeos represents a unique multidisciplinary translational effort for an important clinical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.6M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2023)
- Website: rhaeos.com
- Phone: +1 312-965-5472
Industries & Categories
Health Diagnostics, Medical, Medical Device, Sensor, Wearables
Social Profiles
Canonical: https://fsome.com/organization/rhaeos-58684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.